AB2026-08-005 Medical policies
Capital Blue Cross updated its medical policies, with most changes effective 9/1/2026 or 10/1/2026, and several policies were retired effective 9/1/2026. Capital has delegated medical specialty injectable policies to Prime Medical Pharmacy Solutions (MPS), which revised the Commercial policies to be more medication-specific with updated clinical criteria, and several drug policies now require prior authorization for new products or add new step therapy requirements effective 10/1/2026. Other changes include a cochlear implant age change from 9 months to 7 months, added canthoplasty and canthopexy criteria in the cosmetic and reconstructive surgery policy, and new policies for transurethral water vapor thermal therapy and aquablation and for hydrogel spacer use during radiotherapy for prostate cancer.